PRVA PE Ratio & Valuation,Is PRVA Overvalued

PRVA Relative Valuation

PRVA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PRVA is overvalued; if below, it's undervalued.

Historical Valuation

Privia Health Group Inc (PRVA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 47.29. The fair price of Privia Health Group Inc (PRVA) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：24.34

Fair

94.18

20.63

EV/EBITDA

Privia Health Group Inc. (PRVA) has a current EV/EBITDA of 20.63. The 5-year average EV/EBITDA is 36.98. The thresholds are as follows: Strongly Undervalued below -4.82, Undervalued between -4.82 and 16.08, Fairly Valued between 57.89 and 16.08, Overvalued between 57.89 and 78.79, and Strongly Overvalued above 78.79. The current Forward EV/EBITDA of 20.63 falls within the Historic Trend Line -Fairly Valued range.

65.53

EV/EBIT

Privia Health Group Inc. (PRVA) has a current EV/EBIT of 65.53. The 5-year average EV/EBIT is 1098.38. The thresholds are as follows: Strongly Undervalued below -7559.31, Undervalued between -7559.31 and -3230.46, Fairly Valued between 5427.23 and -3230.46, Overvalued between 5427.23 and 9756.07, and Strongly Overvalued above 9756.07. The current Forward EV/EBIT of 65.53 falls within the Historic Trend Line -Fairly Valued range.

1.37

Privia Health Group Inc. (PRVA) has a current PS of 1.37. The 5-year average PS is 1.95. The thresholds are as follows: Strongly Undervalued below 0.17, Undervalued between 0.17 and 1.06, Fairly Valued between 2.84 and 1.06, Overvalued between 2.84 and 3.73, and Strongly Overvalued above 3.73. The current Forward PS of 1.37 falls within the Historic Trend Line -Fairly Valued range.

25.89

P/OCF

Privia Health Group Inc. (PRVA) has a current P/OCF of 25.89. The 5-year average P/OCF is 45.20. The thresholds are as follows: Strongly Undervalued below 3.94, Undervalued between 3.94 and 24.57, Fairly Valued between 65.84 and 24.57, Overvalued between 65.84 and 86.47, and Strongly Overvalued above 86.47. The current Forward P/OCF of 25.89 falls within the Historic Trend Line -Fairly Valued range.

25.01

P/FCF

Privia Health Group Inc. (PRVA) has a current P/FCF of 25.01. The 5-year average P/FCF is 45.17. The thresholds are as follows: Strongly Undervalued below 4.07, Undervalued between 4.07 and 24.62, Fairly Valued between 65.72 and 24.62, Overvalued between 65.72 and 86.27, and Strongly Overvalued above 86.27. The current Forward P/FCF of 25.01 falls within the Historic Trend Line -Fairly Valued range.

Privia Health Group Inc (PRVA) has a current Price-to-Book (P/B) ratio of 4.22. Compared to its 3-year average P/B ratio of 4.61 , the current P/B ratio is approximately -8.53% higher. Relative to its 5-year average P/B ratio of 6.19, the current P/B ratio is about -31.87% higher. Privia Health Group Inc (PRVA) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.87%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.37% , the current FCF yield is about -100.00% lower.

4.22

P/B

Median3y

4.61

Median5y

6.19

3.61

FCF Yield

Median3y

2.87

Median5y

2.37

Competitors Valuation Multiple

The average P/S ratio for PRVA's competitors is , providing a benchmark for relative valuation. Privia Health Group Inc Corp (PRVA) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 32.54%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of PRVA increased by 24.50% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 0.91 to 1.69.

The secondary factor is the Revenue Growth, contributed 32.54%to the performance.

Overall, the performance of PRVA in the past 1 year is driven by Margin Expansion. Which is more sustainable.

32.54%

437.92M → 580.42M

Revenue Growth

85.71%

0.91 → 1.69

Margin Expansion

-93.75%

2.78K → 173.80

P/E Change

24.50%

19.55 → 24.34

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Privia Health Group Inc (PRVA) currently overvalued or undervalued?

What is Privia Health Group Inc (PRVA) fair value?

PRVA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Privia Health Group Inc (PRVA) is between NaN to NaN according to relative valuation methord.

How does PRVA's valuation metrics compare to the industry average?

What is the current P/B ratio for Privia Health Group Inc (PRVA) as of Dec 16 2025?

As of Dec 16 2025, Privia Health Group Inc (PRVA) has a P/B ratio of 4.22. This indicates that the market values PRVA at 4.22 times its book value.

What is the current FCF Yield for Privia Health Group Inc (PRVA) as of Dec 16 2025?

As of Dec 16 2025, Privia Health Group Inc (PRVA) has a FCF Yield of 0.00%. This means that for every dollar of Privia Health Group Inc’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Privia Health Group Inc (PRVA) as of Dec 16 2025?

As of Dec 16 2025, Privia Health Group Inc (PRVA) has a Forward P/E ratio of 94.18. This means the market is willing to pay $94.18 for every dollar of Privia Health Group Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Privia Health Group Inc (PRVA) as of Dec 16 2025?

As of Dec 16 2025, Privia Health Group Inc (PRVA) has a Forward P/S ratio of 0.00. This means the market is valuing PRVA at $0.00 for every dollar of expected revenue over the next 12 months.

PRVA Valuation